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The nucleotide sequence of a 1.25 kb BgllI/EcoRI fragment from the 34 kb trimethoprim (Tp)-resistant plasmid pABU1 of Staphylococcus aureus 
157/4696, isolated in Ziirich, was determined. It contained the entire Tp-resistant dihydrofolate r duetase gene, 197 bp of the thymidylate synthetase, 
395 bp of a truncated gene and 111 bp of IS257R1. With the exception of one single base pair at position 862 the sequence of the whole fragment 
was identical to nucleotides 1633 to 2885 of the Tp-resistant transposon Tn4003 in plasmid pSK 1 from an Australian S. aureus isolate. This suggests 
the worldwide dissemination fTn4003 in multiresistant S aphylococci. 
Trimethoprim resistance; Dihydrofolate r ductase; Staphylococcus aureus; Transposon Tn4003 
1. INTRODUCTION 
Multiresistant staphylococci, which in addition to 
their methicillin resistance carry resistances to other an- 
tibiotics such as gentamicin, erythromycin or tetra- 
cycline, cause serious therapeutic problems [1]. Cotri- 
moxazole is an effective alternative in the treatment of 
infections by multiresistant staphylococci, but resis- 
tance to Tp, one component of cotrimoxazole, has been 
reported since the early 1980s [2l. The first plasmid- 
encoded Tp-resistant DHFR has recently been describ- 
ed by Young et al. [3]. This DHFR was isolated from a 
multiresistant Staphylococcus aureus from Australia. 
We recently found that a similar or identical enzyme 
was present in a multiresistant Staphylococcus aureus 
from Central Europe [4]. Tp-resistance in this strain 
was transferable and resided on a 28 kb plasmid [1]. In 
this study, we cloned the gene into pUC18, expressed it 
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The nucleotide sequence(s) presented here has (have) been submitted 
to the EMBL/GenBank database under the accession umber no. 
Y07536 
in Escherichia coli and determined its nucleotide se- 
quence. 
2. EXPERIMENTAL 
2.1. Bacterial strains and plasmids 
S.aureus 157/4696 possessing plasmid pABuI (34 kb, Tp r, Pc r, 
Cd r) and S.aureus ATCC 25923 were recently described [1,4]. The 
host strains employed were S.aureus 113 (NCTC 8325 r-m + ) [5] and 
E.coli MI5 (C600-r-AlacM15) [6]. Plasmid pABUla (3.5 kb, Cm r) 
also resides in S.aureus 157/4696. Plasmid pABUI/3 (Aff,Tp r) is 
pUC18, containing a 1.4 kb-EcoR1/HindlI1 fragment of pABUI and 
plasmid pABUI/ l  (Aft, Tp r) is pUCI8, containing a 2.1 kb EcoRl- 
fragment of pABU1. 
2.2. Cloning vectors and restriction enzymes 
The cloning vectors pUCl8, pUCI9 as well as bacteriophage 
MI3mpI8RF, M13mpI9RF [7] and all restriction enzymes were sup- 
plied by Boehringer Mannheim, Switzerland. 
2.3. General methods 
Isolation of plasmids from S.aureus 157/4696 was carried out by 
the alkaline lysis method of Bennett et al. [8] by disrupting the cell 
wall with Lysostaphin (Sigma) and Lysozyme (Pharmacia). Pro- 
toplast ransformation f S.aureus 113 was performed by the method 
of G6tz et al. [9]. Cloning procedures and the use of restriction en- 
zymes followed published procedures [10]. 
The DNA nucleotide sequence was determined with the aid of 
bacteriophage M 13 by the chain termination method of Sanger et al. 
[11]. Fragments were sequenced in two ways: (i) with 35S-dATP and 
the USB Sequenase Kit Version 2.0 and (ii) with the automated se- 
quencer 370A and Taq polymerase (both Applied Biosystems Inc.). 
Purification of DHFR, determination of activity, and kinetic 
parameters were performed as previously described [4]. One unit of 
DHFR activity was taken as the conversion of 1/zmol of dihydrofolate 
per min. 
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Table I
Sensitivity ofdifferent DHFRs towards Tp and MTX 
DHFR source IC~o Tp (,uM) IC5o MTX (nM) 
S.aureus 157/4696 (pABU 1)" 14 
S.aureus 113 (recipient, chromosomal) a 0.08 
S.aureus 113 (pABU 1), transformant a 12 
S.aureus 157/4696 (chromosomal) b 0.04 
E.coli MI5 (recipient, chromosomal)  
E.coli M15 (pABUI/3) a/b 
3.0 
1.4 
3.0 
1.1 
0.01 4.2 
15/19 - /1 .7  
a Determined in crude extract 
b Partially purified enzyme 
June 1990 
3. RESULTS 
3.1. Plasmid isolation and transfer 
S.aureus 157/4696 possesses two plasmids, the 28 kb 
pABU1 (Tpr,pcr,Cd r) and the 3.5 kb (pABUla (Cm~). 
Both plasmids could be transferred toS.aureus 113 via 
protoplast transformation a d selection on DM3 agar 
containing TP (10 mg/l) and Cm (16 mg/1), respective- 
ly. The original strain S.aureus 157/4696 and all 
transformants exhibited high level resistance to Tp 
(minimal inhibitory concentration > 1024 mg/l). 
3.2. Cloning and expression of the DHFR from S. 
aureus 157/4696 in E.coli M15 
A 2.1 kb EcoRI- and a 1.4 kb EcoRI/HindlII frag- 
ment of pABU1 with the intact DHFR-gene (see Fig. 1) 
were cloned into the cloning vector pUC18 used to 
transform E.coli and the Tp-resistant clones were 
selected on Mueller-Hinton agar (Difco) containing Tp 
(10 mg/l)+ Ap (50 mg/l). Specific activity of DHFR, 
determined in crude extracts (corrected for NADPH ox- 
idase activity) were 194 mU/mg protein for S.aureus 
157/4696, 50 mU/mg protein and 49 mU/mg protein 
for the Tp-sensitive strains S.aureus 113 and S.aureus 
ATCC 25923 respectively, 206 mU/mg protein for 
S.aureus 113 (pABU1), 3.6 mU/mg protein for E.coli 
MI5 and 872 mU/mg protein for E.coli M15 (pABUI/ 
3). Concentrations of Tp and MTX which inhibited the 
enzyme activity by 50% (IC5o), were compared for 
several bacterial strains producing these different 
DHFRs and are shown in Table I. 
The sensitivity towards Tp of the plasmid-coded 
DHFR is in the/zM-range, as previously described [4], 
although this enzyme is highly sensitive to MTX 
(IC5o = 3 nM). 
The 2.1 kb EcoRI fragment was characterized more 
precisely by the use of additional restriction endo- 
nucleases and the location of the gene for Tp-resistance 
was defined by subcloning analysis (Fig. 1). 
3.3. Nucleotide sequence of the Tpr-gene 
Two portions of the EcoRI-fragment from pABU1 
were selected for determination f the nucleotide se- 
quence; the 0.8 kb BgllI/HindlII-fragment and the 1.25 
kb BgllI/EcoRI-fragment shown in Fig. 1. Both 
fragments were first subcloned into pUC18 and in a se- 
cond step into M13mpl8RF/MI3mpI9RF. The latter 
contains the entire gene of the Tp-resistant DHFR while 
the former contains only a part of it and did not pro- 
duce Tp r E.coli clones. The sequence of the whole 1.25 
kb BgllI/EcoRI fragment isshown in Fig. 2. Two open 
reading frames (ORF) were recognized on the same 
strand. The first ORF which starts at nucleotide 243 and 
has its stop codon at position 726 could be identified as 
the ORF for the DHFR gene due to the internal HindlII 
site. That this HindlII site interrupts the DHFR gene is 
known from the subcloning analysis. The second ORF 
starts at nucleotide 738 and has its stop codon at posi- 
tion 1158. A third putative ORF lies upstream of these 
two and has its stop codon at position 196. The start 
codon of this putative ORF must lie upstream of the 
EcoRI site which limits the BgllI/EcoRI fragment. 
The first 35 N-terminal amino acid residues of the 
chromosomal DHFR from S.aureus 157/4696 have 
recently been determined [4]. They were compared to 
the sequence of the DHFR from plasmid pABU1 as well 
2.11kbp ~ I 1.4 kbp 0 kbp 
EcoRI Hindlll HindIll BglII EcoRV Sspl Hindlil SspI EcoRl 
Tp r -DHFR 
Fig. 1. Restriction map of the 2.1 kb EcoRI-fragment containing the Tpr-determinant. 
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---~W,-TS 
1 GAATTCATTC ATACATTTGG AGATGCACAT ATTTATTCCA ATCATATGGA 
51 TGCAATACAT ACACAATTAT CAAGAGATAG TTATCTACCA CCTCAATTAA 
i01 A~TTAATAC AGATA~TCA ATTTTTGATA TTAATTATGA AGATTTAGAA 
T$ xxx  
151 TTGATAAATT ATGAATCACA CCCTGCTATT AAAGCACCTA TTGCGGTATA 
O~HFR 
201 A~.%AGATGCA TTAATATTTC GCATACAGAA AGGAGGTATA CCATGACATT 
251 ATCAATAATT GTCGCTCACG ATAAACAAAG AGTCATTGC4G TACC~%AATC 
301 AATTACCTTG GCACTTACCA AATGATTTAA AGCATATTAA ACAACTGACC 
351 ACTGGGAATA CACTTGTAAT GGCACGGAAA CTTTTAATT CTATAGGGAA 
401 C-CCATTGCCA AATAGACGTA ACGTCGTACT CACTAACCAA GCTTCATTTC 
451 ACCATGAAGG GGTAGATGTT ATAAACTCTC TTGATG~-%AT TAAAGAGTTA 
501 TCTGGTCATG TTTTTATATT TGGAGGACAA CGTTATACG AAGCAATGAT 
551 TGACCAGGTA GATGATATGT ATATCACAGT AATAGATGGA AAGTTTCAAG 
601 GAGACACATT CTTTCCACCA TACACATTCG AAAACTGGGA AGTCGAATCT 
651 TCAGTAGAAG GTCAACTAGA TGAA~JLKAAT ACTATACCGC ATACATTCTT 
DHFR ~xx C '~R~I40  
701 ACATTTAGTG CGTAGAA~G GGA~TAGGA C-GCAATTATG GCTAAACAAA 
751 TTATCGTCAC GGATTCAACC TCTGATTTAT CACATGAATA TTTA2kAACAA 
801 CATAACATTC ATGTTATACC ATTAAGCCTG ACAATCGACG GGAAATCTTA 
851 CACTGATCAA GTTGATATCT CTTCAAGTGA GTATATCGAT CATATTGAAA 
901 ATGATGCAGA CGTCAAAACA AGTCAACCAC CTATTGGTCG ATTTATTGAA 
951 ACATATGAGC AATTAGCTCA AGATGACGTT GAAATTATAA GTATTCATCT 
1001 TTCGTCAGGC TTAAGTGGTA CTTATAATAC TGCTGTTCAA C-CGAGCCATA 
1051 TGGTAGATGG TAATATTACA GTGATTGATT CTAAATCTAT TTCGTTTGGG 
C-m-IS257R I 
ii01 TTAGGTTATC AAATTAAGCA AATTGTTGAA TTGGTTCTGT TGCAAAGTAA 
ORFI40xxx 
1151 A~J&AATATAG CTAACCACTA ATTTATCATG TCAGTGTTCG CTTAACTTGC 
1201 TAGCATGATG CTAATTTCGT GGCATGGCGA AATCCGTAG ATC 
Fig. 2. Nucleotide sequence ofthe 115 Bglll/EcoRl fragment from 
pABUI. Arrows with circle indicate start, and xxx stop of ORF. 
as to several other bacterial DHFRs, in order to 
evaluate homologies in the N-terminal region (Fig. 3). 
The highest degree of homology was observed between 
the S.aureus chromosomal DHFR and the DHFR from 
pABU1. 
4. DISCUSSION 
A computer search for homology [17] of the 1.25 kb 
nucleotide sequence with known DNA nucleotide se- 
quences revealed a surprisingly high similarity with part 
of the Tp-resistance transposon Tn4003 from the 
staphylococcal multiresistance plasmid pSK1, which 
has recently been published [12]. The 1.25 kb 
BgllI/EcoRI fragment spans from nucleotide 1633 to 
2885 of Tn4003. Upstream of the Tp-resistance gene it 
contains 197 basepairs of the 3' -end of the TS gene and 
downstream 395 basepairs of the 5'-end of the ORF140 
as well as 111 basepairs of IS257R1. Only one single 
base pair exchange (transition of C into T at position 
862 in the 1.25 kb fragment, corresponding to position 
2494 of Tn4003) within the truncated ORF140 was 
found. Thus the genes for Tp-resistant DHFR from a 
Staphylococcus from Australia and another one from 
Central Europe (strain 157/4696 was isolated in Ziirich, 
Switzerland) are identical, as well as the adjacent se- 
quences of  the gene for TS and IS257RI as far as deter- 
mined. The previously discussed ifferences in some en- 
zymatic parameters between the SI and the enzyme 
from S.aureus 157/4696 are therefore due to experi- 
mental variation and not to differences in the protein 
[4]. This leads to the assumption that transposon 
Tn4003 has spread worldwide, since a DNA probe of 
the S1 DHFR from plasmid pSK1 also hybridized to 
DNA from strains from North America (S.G.B. 
Amyes, and S. Tait, personal communication). This 
highly conserved sequence of the Tp-resistant staphy- 
lococcal DHFR is surprising when compared to the 
multitude of Tp-resistant DHFRs found in Gram- 
negative bacteria [18], where even among the same type 
sequence differences are found. The type II enzymes 
from plasmids R388 and R67 e.g. differ in 17 out of 78 
amino acids [19]. 
S.aureu$157/4696 (pABU1) 
S.aureus (pSK1) 
S.aureus (chromosomal) 
E.coli KI2 (chromosomal) 
E.coli (Tn7) 
L.casei 
S.faecium 
10 20 3o 
MTLS I IVAHDKQRVIGYQNQLP WH LPNDLKH IKQLT  
MTLS  I IVAHDKQRV IGYQNQ LPWH LPNDLKH IKQLT  10 0 
TLS  I LVAHDLQRVIGFENQLPWHLPNDLKHVKKLS 8 0 
MI  S L IAALAVDRVIGMENAMPWNLP AD LAWF KRNT 4 6 
VKLS  LMVAI  SKNGVIGNGPD I PWSAKGEQLLFKAI  T 3 4 
TAF  LWAQNRDGL I GKDGH LPWH LPDD LHYFKAQT 37 
MF  I SMWAQDKNGL I GKDGLLP  WRLPNDMRF FREHT 37 
Fig. 3. Similarities inthe amino acid sequence at the N-terminus (first 35 residues) ofseveral bacterial DHFRs. Sequence r ferences are: S.aureus 
(pSK1) [12], S.aureus 157/4696 chromosomal DHFR [4], E.coli KI2 chromosomal DHFR [131, E.coli type I DHFR (Tn7) [14], L.casei DHFR 
[15], S.faecium [161. 
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The question of the origin of the Tp-resistant 
staphylococcal DHFR is highly interesting. The com- 
parison carried out by Rouch et al. [12] led them to sug- 
gest a chromosomal gene of a Gram-positive bacterium 
such as Bacillus as ancestor. The comparison of the 
staphylococcal S1 enzyme with other DHFRs gave 33% 
overall amino acid homology with the enzymes from 
B.subtilis, L.casei and S.faecium and slightly less for 
E.coli. However, as shown in Fig. 3, 80% homology is
found between the chromosomal S.aureus DHFR and 
the plasmid derived enzyme from Tn4003 or from 
plasmid pABU1 although only 35 amino acids of the 
chromosomal staphylococcal enzyme have as yet been 
determined [4]. Six of the seven amino acids which dif- 
fer between this enzyme and the Tn4003 coded DHFR 
can be explained by a single base pair exchange. Unless 
the full sequence of the chromosomal S.aureus DHFR 
proves to possess a much lesser degree of overall 
homology than the 35 residues at the amino terminus, 
we assume that this enzyme derives from the Tp- 
sensitive chromosomal S.aureus DHFR. Further sup- 
port for this assumption is the possibility of selecting 
Tp-resistant S.aureus by serial passages over increasing 
concentrations of Tp. The mutant strains obtained har- 
boured DHFRs with reduced sensitivity towards Tp, 
but nearly unchanged sensitivity towards MTX, 
showing behaviour very similar to that of the S1 enzyme 
(unpublished results). Once such a mutation has occur- 
red under selection pressure of Tp, the mutated gene 
could have transposed from the chromosome to a 
plasmid with the aid of IS257 elements. To resolve this 
question, the full sequence of the chromosomal DHFR 
gene from S.aureus will have to be determined. The 
failure to cross-hybridize type S1 DHFR DNA with 
S.aureus chromosomal DNA [20] may be due to a lack 
of specificity of the probe used. We are presently 
employing a 0.58 kb SspI fragment, which includes the 
whole gene for the DHFR, as a probe, in order to col- 
lect more information on the dissemination f the Tp- 
resistance gene among staphylococci and preliminary 
experiments indicate hybridization of this probe with 
the chromosomal DNA of S.aureus ATCC 25923. 
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